We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Exxon Mobil, Coca-Cola, Thermo Fisher Scientific, The Progressive, and Dominion Energy
Read MoreHide Full Article
For Immediate Release
Chicago, IL – June 13, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Exxon Mobil Corp. (XOM - Free Report) , The Coca-Cola Co. (KO - Free Report) , Thermo Fisher Scientific Inc. (TMO - Free Report) , The Progressive Corp. (PGR - Free Report) , and Dominion Energy, Inc. (D - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Stock Reports for Exxon Mobil, Coca-Cola and Thermo Fisher
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corp., The Coca-Cola Co., and Thermo Fisher Scientific Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Exxon Mobil shares have outperformed the Zacks Oil and Gas - Integrated - International industry over the past year (+71.4% vs. +55.9%). The company's bellwether status and an optimal integrated capital structure that has historically produced industry-leading returns make it a relatively lower-risk energy sector play.
The company made three oil discoveries in the Stabroek Block, which will increase its recoverable resources estimates to 11 billion oil-equivalent barrels. It also has a strong presence in the prolific Permian Basin, where it continues to lower its fracking & drilling costs.
To capitalize on mounting demand for clean energy, ExxonMobil is making efforts to create more efficient fuels while reducing emissions. Notably, it has significantly lower debt exposure than other integrated majors. ExxonMobil has increased its stock repurchase program from $10 billion to $30 billion. The energy giant has planned to execute the repurchases through next year.
Coca-Cola shares have outperformed the Beverages - Soft drinks industry over the past year (+14.0% vs. +8.2%). The company benefited from the strategic transformation and ongoing recovery around the world. Strength across the majority of the markets, investments in the marketplace, recovery in certain markets as well as the cycling of last year's pandemic-led impacts aided volumes.
The company retained its upbeat 2022 view. It is poised to gain from innovations and accelerating digital investments.
However, pressures from higher supply chain costs, including transportation and input costs remain. Higher marketing spending are also concerning. Also, the unfavorable currency is expected to hurt the top and bottom lines in the second quarter and 2022.
Thermo Fisher shares have outperformed the Medical - Instruments industry over the past year (+16.4% vs. -21.1%). The company's robust year-over-year revenue growth in the Analytical Instruments and the Laboratory Products and Biopharma Services segments appears promising.
The company's strategic acquisitions of PPD, Inc. and PeproTech raise investors' confidence. Thermo Fisher's accelerated investments to expand bioproduction capacity also buoy optimism. The upbeat guidance for 2022 is indicative that this growth momentum will continue.
However, the year-over-year decline in revenues in the Specialty Diagnostics segment is disappointing. The contraction of both margins does not bode well either.
Other noteworthy reports we are featuring today include The Progressive Corp., and Dominion Energy, Inc.
Why Haven't You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights Exxon Mobil, Coca-Cola, Thermo Fisher Scientific, The Progressive, and Dominion Energy
For Immediate Release
Chicago, IL – June 13, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Exxon Mobil Corp. (XOM - Free Report) , The Coca-Cola Co. (KO - Free Report) , Thermo Fisher Scientific Inc. (TMO - Free Report) , The Progressive Corp. (PGR - Free Report) , and Dominion Energy, Inc. (D - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Stock Reports for Exxon Mobil, Coca-Cola and Thermo Fisher
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corp., The Coca-Cola Co., and Thermo Fisher Scientific Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Exxon Mobil shares have outperformed the Zacks Oil and Gas - Integrated - International industry over the past year (+71.4% vs. +55.9%). The company's bellwether status and an optimal integrated capital structure that has historically produced industry-leading returns make it a relatively lower-risk energy sector play.
The company made three oil discoveries in the Stabroek Block, which will increase its recoverable resources estimates to 11 billion oil-equivalent barrels. It also has a strong presence in the prolific Permian Basin, where it continues to lower its fracking & drilling costs.
To capitalize on mounting demand for clean energy, ExxonMobil is making efforts to create more efficient fuels while reducing emissions. Notably, it has significantly lower debt exposure than other integrated majors. ExxonMobil has increased its stock repurchase program from $10 billion to $30 billion. The energy giant has planned to execute the repurchases through next year.
(You can read the full research report Exxom Mobil here >>>)
Coca-Cola shares have outperformed the Beverages - Soft drinks industry over the past year (+14.0% vs. +8.2%). The company benefited from the strategic transformation and ongoing recovery around the world. Strength across the majority of the markets, investments in the marketplace, recovery in certain markets as well as the cycling of last year's pandemic-led impacts aided volumes.
The company retained its upbeat 2022 view. It is poised to gain from innovations and accelerating digital investments.
However, pressures from higher supply chain costs, including transportation and input costs remain. Higher marketing spending are also concerning. Also, the unfavorable currency is expected to hurt the top and bottom lines in the second quarter and 2022.
(You can read the full research report Coca-Cola here >>>)
Thermo Fisher shares have outperformed the Medical - Instruments industry over the past year (+16.4% vs. -21.1%). The company's robust year-over-year revenue growth in the Analytical Instruments and the Laboratory Products and Biopharma Services segments appears promising.
The company's strategic acquisitions of PPD, Inc. and PeproTech raise investors' confidence. Thermo Fisher's accelerated investments to expand bioproduction capacity also buoy optimism. The upbeat guidance for 2022 is indicative that this growth momentum will continue.
However, the year-over-year decline in revenues in the Specialty Diagnostics segment is disappointing. The contraction of both margins does not bode well either.
(You can read the full research report Thermo Fisher here >>>)
Other noteworthy reports we are featuring today include The Progressive Corp., and Dominion Energy, Inc.
Why Haven't You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.